Jushi Holdings Director Granted 100,000 Stock Options
Jushi Holdings Inc.
Subscribe to track JUSHF
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Jushi Holdings Director Granted 100,000 Stock Options
Company: Jushi Holdings Inc. (JUSHF) Form: 4 | Filed: 2025-12-15 Significance: Low
Insider: Monroe Stephen Title: Director
Transaction: • Type: Grant (Stock Option) • Shares: 100,000 • Price: $0.00 • Value: $0 • Owned After: 100,000 options
Key Insight: A director received a standard equity compensation grant, aligning their interests with shareholders. The options have a 3-year vesting schedule and an exercise price of $0.50.
Market Context: This is a routine compensation event, not an open-market transaction, and carries low trading significance.
Comprehensive Analysis
SEC Filing Analysis: Jushi Holdings Inc. (JUSHF)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director, Stephen Monroe, was granted 100,000 stock options as part of a standard compensation package.
- Market Impact: Neutral. This is a routine grant of equity compensation and not an open-market transaction, thus it is not a strong indicator of insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Jushi Holdings Inc. |
| Ticker Symbol | JUSHF |
| CIK | 0001909747 |
| Industry | Medicinal Chemicals & Botanical Products |
Insider Information
| Field | Value |
|---|---|
| Name | Monroe Stephen |
| CIK | 0001939766 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-11 |
| Transaction Code | A (Grant) |
| Security Type | Stock Option (right to buy) |
| Shares Involved | 100,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 100,000 |
| Ownership Type | Direct |
Financial Impact Assessment
Impact Evaluation
As market capitalization and shares outstanding data are unavailable, a quantitative assessment of the transaction's materiality is not possible. However, grants of this nature are common for board members and are intended to align insider interests with those of shareholders over the long term.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market transaction representing compensation. It does not signal an insider's decision to buy or sell shares with their own capital at current market prices.
Volume & Sentiment
- Expected Volume Impact: None. The grant does not involve an open-market trade.
- Sentiment Indicator: Neutral. This is a standard corporate governance action.
Additional Context
Transaction Notes
- Vesting Schedule: The options vest in three equal installments annually, beginning on December 11, 2026. This structure encourages long-term service.
- Exercise Price: The options have an exercise price of $0.50 and expire in ten years, on December 11, 2035.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
